Simplex Trading, LLC Veracyte, Inc. Transaction History

Simplex Trading, LLC

$2.81 Billion
Q3 2024

A detailed history of Simplex Trading, LLC transactions in Veracyte, Inc. stock. As of the latest transaction made, Simplex Trading, LLC holds 1,285 shares of VCYT stock, worth $51,965. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,285

Holding current value

$51,965

% of portfolio

0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	BUY	$21.0 - $35.25 $26,985 - $45,296	1,285 New	1,285 $43,000
Q1 2024 Apr 25, 2024	SELL	$21.0 - $29.1 $173,670 - $240,657	-8,270 Reduced 99.01%	83 $1,000
Q4 2023 Feb 02, 2024	BUY	$19.72 - $28.68 $92,210 - $134,107	4,676 Added 127.17%	8,353 $229,000
Q3 2023 Nov 01, 2023	BUY	$22.33 - $29.92 $63,461 - $85,032	2,842 Added 340.36%	3,677 $82,000
Q2 2023 Aug 04, 2023	BUY	$20.96 - $26.99 $17,501 - $22,536	835 New	835 $21,000
Q4 2022 Feb 02, 2023	BUY	$15.31 - $29.94 $13,748 - $26,886	898 Added 56.48%	2,488 $59,000
Q3 2022 Nov 04, 2022	BUY	$16.58 - $27.9 $11,440 - $19,251	690 Added 76.67%	1,590 $26,000
Q2 2022 Aug 03, 2022	SELL	$15.45 - $29.52 $54,862 - $104,825	-3,551 Reduced 79.78%	900 $17,000
Q1 2022 May 02, 2022	SELL	$21.94 - $42.51 $44,165 - $85,572	-2,013 Reduced 31.14%	4,451 $122,000
Q4 2021 Feb 23, 2022	BUY	$36.09 - $53.79 $199,397 - $297,189	5,525 Added 588.39%	6,464 $266,000
Q2 2021 Aug 12, 2021	SELL	$32.94 - $56.62 $156,497 - $269,001	-4,751 Reduced 83.5%	939 $37,000
Q1 2021 Apr 26, 2021	BUY	$44.47 - $81.38 $248,720 - $455,158	5,593 Added 5765.98%	5,690 $305,000
Q4 2020 Feb 02, 2021	BUY	$32.49 - $61.88 $3,151 - $6,002	97 New	97 $4,000
Q2 2020 Jul 13, 2020	SELL	$19.49 - $28.11 $31,632 - $45,622	-1,623 Closed	0 $0
Q1 2020 Apr 29, 2020	SELL	$16.13 - $30.17 $34,550 - $64,624	-2,142 Reduced 56.89%	1,623 $39,000
Q4 2019 Feb 05, 2020	SELL	$20.78 - $29.99 $218,169 - $314,865	-10,499 Reduced 73.6%	3,765 $105,000
Q3 2019 Oct 15, 2019	BUY	$23.87 - $30.93 $108,465 - $140,545	4,544 Added 46.75%	14,264 $342,000
Q2 2019 Jul 26, 2019	BUY	$22.1 - $28.56 $214,812 - $277,603	9,720 New	9,720 $277,000
Q1 2019 Apr 18, 2019	SELL	$12.0 - $25.76 $110,808 - $237,867	-9,234 Closed	0 $0
Q4 2018 Jan 16, 2019	BUY	$9.15 - $14.85 $84,491 - $137,124	9,234 New	9,234 $116,000
Q2 2018 Jul 30, 2018	SELL	$5.39 - $9.66 $131,381 - $235,462	-24,375 Closed	0 $0
Q1 2018 Apr 26, 2018	BUY	$5.44 - $6.97 $33,744 - $43,234	6,203 Added 34.13%	24,375 $135,000
Q4 2017 Jan 10, 2018	BUY	$6.05 - $9.37 $834 - $1,293	138 Added 0.77%	18,172 $118,000
Q3 2017 Oct 25, 2017	BUY	$7.81 - $8.77 $140,845 - $158,158	18,034	18,034 $158,000

Others Institutions Holding VCYT

# of Institutions

307

Shares Held

81.7M

Call Options Held

134K

Put Options Held

13.3K

Black Rock Inc. New York, NY

7.79M
Shares

$315 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

7.75M
Shares

$313 Million
0.0% of portfolio
Artisan Partners Limited Partnership Milwaukee, WI

5.02M
Shares

$203 Million
0.27% of portfolio
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl

4.92M
Shares

$199 Million
1.59% of portfolio
Wellington Management Group LLP Boston, MA

4.23M
Shares

$171 Million
0.03% of portfolio

View Full List

About VERACYTE, INC.

Ticker VCYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,575,904
Market Cap $2.89B
Description
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...

More about VCYT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.

Account